Takeda Pharmaceutical Operating Income 2007-2019 | TAK

Takeda Pharmaceutical annual/quarterly operating income history and growth rate from 2007 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Takeda Pharmaceutical operating income for the quarter ending December 31, 2019 was $0.492B, a 45.88% decline year-over-year.
  • Takeda Pharmaceutical operating income for the twelve months ending December 31, 2019 was $1.959B, a 56.4% decline year-over-year.
  • Takeda Pharmaceutical annual operating income for 2020 was $0.924B, a 49.92% decline from 2019.
  • Takeda Pharmaceutical annual operating income for 2019 was $1.845B, a 15.23% decline from 2018.
  • Takeda Pharmaceutical annual operating income for 2018 was $2.176B, a 50.12% increase from 2017.
Takeda Pharmaceutical Annual Operating Income
(Millions of US $)
2020 $924
2019 $1,845
2018 $2,176
2017 $1,450
2016 $1,086
2015 $-1,176
2014 $1,393
2013 $1,482
2012 $3,366
2011 $4,423
2010 $4,518
2009 $3,127
2008 $4,231
2007 $3,886
2006 $3,443
Takeda Pharmaceutical Quarterly Operating Income
(Millions of US $)
2019-12-31 $492
2019-09-30 $376
2019-06-30 $90
2018-12-31 $1,001
2018-06-30 $910
2017-06-30 $1,755
2016-06-30 $1,422
2015-06-30 $406
2015-03-31 $3,673
2014-12-31 $-10,919
2014-09-30 $4,076
2014-06-30 $612
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $509
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $892
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
2008-03-31 $2,839
2007-03-31 $2,525
2006-03-31 $2,371
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $60.060B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.693B 38.42
Astellas Pharma (ALPMY) Japan $33.206B 16.58
Eisai (ESALY) Japan $23.933B 44.59
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $15.425B 20.23
Grifols, S.A (GRFS) Spain $13.538B 16.83
Catalent (CTLT) United States $12.243B 47.33
Neurocrine Biosciences (NBIX) United States $11.054B 51.09
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.916B 42.09
Orion OYJ (ORINY) Finland $7.289B 32.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.270B 0.00
IPSEN SA ADR (IPSEY) France $6.744B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.570B 10.52
United Therapeutics (UTHR) United States $5.532B 10.48
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.239B 12.89
Evotec AG (EVTCY) Germany $4.117B 66.40
Nektar Therapeutics (NKTR) United States $4.028B 0.00
ChemoCentryx (CCXI) United States $3.747B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.258B 355.67
PTC Therapeutics (PTCT) United States $3.139B 0.00
FibroGen (FGEN) United States $2.958B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.612B 10.74
Cronos Group (CRON) Canada $2.253B 64.60
Pacira BioSciences (PCRX) United States $1.943B 39.76
Sage Therapeutics (SAGE) United States $1.869B 0.00
USANA Health Sciences (USNA) United States $1.807B 18.53
Xencor (XNCR) United States $1.703B 0.00
Heron Therapeutics (HRTX) United States $1.700B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.686B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.681B 0.00
Corcept Therapeutics (CORT) United States $1.662B 16.48
Zogenix (ZGNX) United States $1.645B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.602B 12.26
Akebia Therapeutics (AKBA) United States $1.548B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.434B 15.45
Portola Pharmaceuticals (PTLA) United States $1.407B 0.00
Karyopharm Therapeutics (KPTI) United States $1.287B 0.00
Tilray (TLRY) Canada $1.257B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.165B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.019B 45.49
Translate Bio (TBIO) United States $1.016B 0.00
Endo (ENDP) Ireland $0.919B 1.42
ImmunoGen (IMGN) United States $0.825B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.794B 0.00
Molecular Templates (MTEM) United States $0.734B 0.00
Indivior (INVVY) United States $0.731B 9.07
Collegium Pharmaceutical (COLL) United States $0.721B 0.00
Aerie Pharmaceuticals (AERI) United States $0.705B 0.00
Ardelyx (ARDX) United States $0.622B 0.00
Trillium Therapeutics (TRIL) Canada $0.617B 0.00
Radius Health (RDUS) United States $0.584B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.523B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.484B 0.00
DURECT (DRRX) United States $0.480B 0.00
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.460B 11.13
Organogenesis Holdings (ORGO) United States $0.447B 0.00
Harpoon Therapeutics (HARP) United States $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.429B 16.77
MEI Pharma (MEIP) United States $0.401B 0.00
Calithera Biosciences (CALA) United States $0.380B 0.00
Ocular Therapeutix (OCUL) United States $0.369B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.315B 0.00
TherapeuticsMD (TXMD) United States $0.304B 0.00
Lannett Co Inc (LCI) United States $0.301B 6.61
Avadel Pharmaceuticals (AVDL) Ireland $0.300B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
CASI Pharmaceuticals (CASI) United States $0.267B 0.00
Rafael Holdings (RFL) United States $0.253B 0.00
Redhill Biopharma (RDHL) Israel $0.246B 0.00
OptiNose (OPTN) United States $0.232B 0.00
KalVista Pharmaceuticals (KALV) United States $0.207B 0.00
VAXART, INC (VXRT) United States $0.203B 0.00
PROFOUND MEDICL (PROF) Canada $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.192B 25.26
Jounce Therapeutics (JNCE) United States $0.191B 4.56
IMV INC (IMV) Canada $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Xeris Pharmaceuticals (XERS) United States $0.172B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Altimmune (ALT) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.116B 0.00
Recro Pharma (REPH) United States $0.109B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.105B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
Sundial Growers (SNDL) Canada $0.088B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
Otonomy (OTIC) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.080B 0.00
Onconova Therapeutics (ONTX) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.076B 0.00
CV Sciences (CVSI) United States $0.075B 0.00
Hemispherx BioPharma (AIM) United States $0.074B 0.00
Heat Biologics (HTBX) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.060B 0.00
Biomerica (BMRA) United States $0.060B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.55
Opiant Pharmaceuticals (OPNT) United States $0.049B 105.00
IsoRay (ISR) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
GTx (ONCT) United States $0.044B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Lipocine (LPCN) United States $0.042B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 7.26
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
AgeX Therapeutics (AGE) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Novan (NOVN) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00